Mithra Pharmaceuticals S.A.
MITPF · OTC
12/31/2023 | 6/30/2023 | 12/31/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$123,033 | -$50,469 | -$28,373 | -$31,247 |
| Dep. & Amort. | $6,060 | $6,154 | $6,112 | $5,828 |
| Deferred Tax | $45,999 | $39,881 | -$38,188 | -$18,801 |
| Stock-Based Comp. | $5,161 | $0 | $1,498 | $485 |
| Change in WC | -$63,280 | $51,568 | -$24,466 | -$6,660 |
| Other Non-Cash | $117,950 | -$37,554 | $54,755 | $12,376 |
| Operating Cash Flow | -$11,143 | $8,959 | -$28,662 | -$38,019 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $302 | -$5,598 | -$13,365 | -$12,293 |
| Net Acquisitions | $0 | $0 | -$1 | $170 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $10,208 | $0 | $0 |
| Other Inv. Act. | $789 | -$2,250 | -$1 | -$8,539 |
| Investing Cash Flow | $1,091 | $2,361 | -$13,366 | -$12,124 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$18,084 | $0 | -$2,296 |
| Stock Issued | $0 | $2,500 | $1,165 | $48,876 |
| Stock Repurch. | -$2,500 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,184 | $2,230 | $41,151 | $48,876 |
| Financing Cash Flow | -$4,684 | -$15,854 | $41,151 | $46,580 |
| Forex Effect | $2 | -$37 | -$137 | -$10 |
| Net Chg. in Cash | -$14,734 | -$4,571 | -$1,014 | -$3,573 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $23,714 | $28,285 | $29,299 | $32,872 |
| End Cash | $8,980 | $23,714 | $28,285 | $29,299 |
| Free Cash Flow | -$10,841 | $3,361 | -$42,027 | -$50,312 |